DRKS00023356招募中不适用
Clinical relevance of KRAS and GNAS Mutationen in cell-free DNA and circulating epithelial cells regarding the development of pancreatic cancer in IPMN patients - IPM
niversitätsklinikum Hamburg-Eppendorf0 个研究点目标入组 100 人开始时间: 2021年3月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •IPMN diagnosis; written consent
排除标准
- •no written consent
研究者
相似试验
招募中
Unknown
Evaluation the clinical utility of KRAS mutation assay using tumor samples (tissue, cytology) and blood samples in patients with pancreatic cancer.pancreatic cancerJPRN-UMIN000052237St.Marianna University School of Medicine100
已完成
不适用
A clinical study of relevance to KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerColorectal cancerJPRN-UMIN000013154Department of Medical Oncology, Niigata University Graduate School of Medical and Dental Sciences20
招募中
不适用
Comparative analysis of KRAS and EGFR mutation detection in liquid biopsy vs tissue biopsy in patients with NSCLCNon-small-cell lung carcinoma10038666lung cancerNL-OMON48625Jeroen Bosch Ziekenhuis150
尚未招募
不适用
Prevalence of two mutations (KRAS and BRAF) in patients diagnosed with Colorectal Cancer.CTRI/2013/09/004023Dr Prachi S Patil200
已完成
不适用
Effects of mutations in KRAS and BRAF gene and histological parameters on the clinical course of disease in patients with metastatic colorectal cancerMetastatic colorectal cancerMalignant neoplasm of colonCancerISRCTN10604174Institute of Oncology Ljubljana (Slovenia)400